Beskrivelse
Krav
IPC-klasse
Fullmektig i Norge:
Org.nummer: 925400262
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2013.03.14, US 201361784903 P
2013.12.23, US 201361920165 P
ANDREW J GEALL ET AL: "Nonviral delivery of self-amplifying RNA vaccines", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, NATIONAL ACADEMY OF SCIENCES, US, vol. 109, no. 36, 4 September 2012 (2012-09-04), pages 14604-14609, XP002683929, ISSN: 0027-8424, DOI: 10.1073/PNAS.1209367109 [retrieved on 2012-08-20] (B1)
XINGFANG SU ET AL: "In Vitro and in Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles", MOLECULAR PHARMACEUTICS, vol. 8, no. 3, 6 June 2011 (2011-06-06), pages 774-787, XP055127583, ISSN: 1543-8384, DOI: 10.1021/mp100390w (B1)
Ian MacLachlan: "Liposomal Formulatioons for Nucleic Acid Delivery" In: Stanley T. Crooke: "Antisense Drug Technology", 1 January 2008 (2008-01-01), Taylor and Francis Group, Boca Raton ISBN: 0-8493-8796-5 pages 237-270, (B1)
K. T. Love ET AL: "Lipid-like materials for low-dose, in vivo gene silencing", Proceedings of the National Academy of Sciences, vol. 107, no. 5, 2 February 2010 (2010-02-02), pages 1864-1869, XP055077922, ISSN: 0027-8424, DOI: 10.1073/pnas.0910603106 (B1)
MARTINON F ET AL: "INDUCTION OF VIRUS-SPECIFIC CYTOTOXIC T LYMPHOCYTES IN VIVO BY LIPOSOME-ENTRAPPED MRNA", EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY VCH, WEINHEIM, vol. 23, 1 January 1993 (1993-01-01), pages 1719-1722, XP000618955, ISSN: 0014-2980, DOI: 10.1002/EJI.1830230749 (B1)
MORITZ THRAN ET AL: "mRNA mediates passive vaccination against infectious agents, toxins, and tumors", EMBO MOLECULAR MEDICINE (ONLINE), vol. 9, no. 10, 9 August 2017 (2017-08-09) , pages 1434-1447, XP055505303, DE ISSN: 1757-4684, DOI: 10.15252/emmm.201707678 (B1)
Mamoru Nakanishi ET AL: "New Transfection Agents Based on Liposomes Containing Biosurfactant MEL-A", Pharmaceutics, vol. 5, no. 3, 16 August 2013 (2013-08-16) , pages 411-420, XP055435942, DOI: 10.3390/pharmaceutics5030411 (B1)
Michela Pisani ET AL: "Neutral Liposomes and DNA Transfection" In: "Non-Viral Gene Therapy", 7 November 2011 (2011-11-07), InTech, XP055771046, ISBN: 978-953-30-7538-9 DOI: 10.5772/21283, (B1)
Michela Pisani, Giovanna Mobbili and Paolo Bruni: "Neutral Liposomes and DNA Transfection, Non-Viral Gene Therapy" In: Prof. Xubo Yuan: "Non-Viral Gene Therapy", 7 November 2011 (2011-11-07) ISBN: 978-953-307-538-9 DOI: http://www.intechopen.com/books/non-viral- gene-therapy/neutral-liposomes-and-dna-tra nsfection, (B1)
PHILIPPOT J ET AL: "A very mild method allowing the encapsulation of very high amounts of macromolecules into very large (1000 nm) unilamellar liposomes", BIOCHIMICA ET BIOPHYSICA ACTA (BBA) - BIOMEMBRANES, ELSEVIER, AMSTERDAM, NL, vol. 734, no. 2, 12 October 1983 (1983-10-12), pages 137-143, XP023509291, ISSN: 0005-2736, DOI: 10.1016/0005-2736(83)90111-6 [retrieved on 1983-10-12] (B1)
US-A1- 2012 237 975 (B1)
WO-A1-2011/068810 (B1)
WO-A1-2012/170930 (B1)
WO-A2-2008/083949 (B1)
GEERTRUI TAVERNIER ET AL: "mRNA as gene therapeutic: How to control protein expression", JOURNAL OF CONTROLLED RELEASE, vol. 150, no. 3, 1 March 2011 (2011-03-01) , pages 238-247, XP055068617, ISSN: 0168-3659, DOI: 10.1016/j.jconrel.2010.10.020 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Varsel om betaling av første årsavgift (3319) (PTEP2970456)
|
Utgående
EP Registreringsbrev (3210) (PTEP2970456)
|
Innkommende, AR439445183
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Neste fornyelse/årsavgift:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 12. avg. år (EP) | 2025.03.12 | 5010 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 11. avg. år (EP) | 2024.02.22 | 3500 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 10. avg. år (EP) | 2023.03.09 | 3200 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 9. avg. år (EP) | 2022.02.24 | 2850 | MASTER DATA CENTER INC | Betalt og godkjent |
32111428 expand_more expand_less | 2021.08.20 | 5500 | OSLO PATENTKONTOR AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|